Sangamo Therapeutics (SGMOQ) Assets Average (2011 - 2025)

Sangamo Therapeutics has reported Assets Average for 15 years, with the latest figure at $74.2 million in Q4 2025.

• On a quarterly basis, Assets Average fell 30.3% year-over-year to $74.2 million in Q4 2025; TTM through Dec 2025 was $74.2 million, a 30.3% decrease from a year earlier, with the FY2025 full-year figure at $80.7 million, down 39.55% from the prior year.
• Assets Average was $74.2 million for Q4 2025 at Sangamo Therapeutics, down from $93.1 million in the prior quarter.
• The five-year high for Assets Average was $907.8 million in Q1 2021, with the low at $74.2 million in Q4 2025.
• Average Assets Average over 5 years is $399.6 million, with a median of $327.6 million recorded in 2023.
• The sharpest annual moves came in 2021 and 2024: Assets Average jumped 48.61% in 2021, then tumbled 71.01% in 2024.
• Over 5 years, Assets Average stood at $747.2 million in 2021, then retreated by 22.61% to $578.2 million in 2022, then sank by 66.71% to $192.5 million in 2023, then plunged by 44.7% to $106.4 million in 2024, then slumped by 30.3% to $74.2 million in 2025.
• The last three Assets Average figures came in at $74.2 million (Q4 2025), $93.1 million (Q3 2025), and $91.9 million (Q2 2025), per Business Quant data.